Local therapy as a treatment strategy in EGFR-mutant advanced lung cancers that have developed acquired resistance to EGFR tyrosine kinase inhibitors.
Helena Alexandra Yu
No relevant relationships to disclose
Camelia S. Sima
No relevant relationships to disclose
Alexander Edward Dela Cruz Drilon
No relevant relationships to disclose
Anna M. Varghese
No relevant relationships to disclose
Maria Catherine Pietanza
No relevant relationships to disclose
Christopher G. Azzoli
No relevant relationships to disclose
Naiyer A. Rizvi
No relevant relationships to disclose
Lee M. Krug
Consultant or Advisory Role - Genentech
Mark G. Kris
No relevant relationships to disclose
Vincent A. Miller
Employment or Leadership Position - Foundation Medicine
Consultant or Advisory Role - Astellas Pharma; Boehringer Ingelheim; Clovis Oncology; Genentech
Stock Ownership - Foundation Medicine
Gregory J. Riely
Consultant or Advisory Role - Abbott Laboratories; ARIAD; Chugai Pharma; Daiichi Sankyo; Tragara
Research Funding - Bristol-Myers Squibb; GlaxoSmithKline; Infinity; Merck; Pfizer